Why were AstraZenecas marketing claims problematic?
The complaint claims that AstraZeneca’s marketing messages for Nexium are misleading. AstraZeneca’s claims that Nexium is superior to Prilosec are based on clinical studies that compared 40mg of Nexium to 20mg of Prilosec, and found Nexium, even at twice the dose, to be only slightly more effective. The complaint argues that if the drugs were compared at standard doses, Nexium would not have been found more effective.
